Physician profile
Christopher P Powers
NPI 1497098792
$5,523.74
in general payments reported to CMS, 2019-2025
17 companies · $2,149 in 2025
The $2,149 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $59.82 · 2021: $1,415 · 2022: $33.47 · 2023: $1,114 · 2024: $272 · 2025: $2,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,932 · Food and Beverage: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,932.19 |
| Food and Beverage | $1,603.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,162.18 | 2024-2025 | |
| Prodigy Surgical Distribution, INC. | $1,763.21 | 2021-2023 | |
| Arthrex, INC. | $468.48 | 2023 | |
| Smith+Nephew, INC. | $371.25 | 2019-2025 | Renasys Go V2 Home, Pico, Collagenase Santyl |
| Horizon Therapeutics Plc | $286.24 | 2019-2021 | |
| Bioventus LLC | $162.61 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $80.02 | 2022-2024 | Nuzyra |
| Nevro Corp. | $52.78 | 2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $30.54 | 2025 | |
| Averitas Pharma INC. | $26.46 | 2025 | Qutenza |
| Convatec INC. | $25.54 | 2025 | |
| Advanced Oxygen Therapy INC. | $20.29 | 2020 | |
| Amgen INC. | $16.54 | 2025 | Krystexxa |
| Ani Pharmaceuticals, INC. | $16.31 | 2025 | Purified Cortrophin Gel |
| Baudax Bio INC. | $15.66 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $13.98 | 2022 | |
| Depuy Synthes Sales INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.